1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA BRSK2 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA DOK6 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA TDG CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA EPM2A CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA MTNR1A CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA CA6 CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA RAB1A CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA CRMP1 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA TAF5 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA MAMDC4 CTRPv2 pan-cancer AAC 0.16 2e-06
Download CSV